DALLAS, Nov. 19, 2025 /PRNewswire/ -- Dialectic Therapeutics, Inc., a clinical-stage biotechnology company developing innovative anti-cancer drugs, today announced that patient dosing is underway in a ...

JSKN003 has shown a 63% objective response rate and 7.7 months median progression-free survival in PROC patients, with higher efficacy in HER2-positive subgroups. The FDA's fast track designation ...

"The interim results demonstrated a highly differentiated clinical profile for TUB-040 in the ADC field, with anti-tumor activity beginning at low doses with a broad therapeutic window that could ...

Microsoft has announced the release of SQL Server Management Studio Preview 3, which brings many features, including "initial" support for ARM64. SQL Server Management Studio (SSMS) is the tool of ...

A new SQL Server 2025 feature lets organizations run vector-based semantic searches on their own data, connecting to local or cloud-hosted AI models without relying on massive general-purpose LLMs. I ...

Lynsi Snyder, president and owner of In-N-Out, is speaking out after social media users criticized her for comments she made about the chain's home state of California. "I’m very proud of where ...

In-N-Out Burger owner Lynsi Snyder will be moving her family to Tennessee as the company expands eastward. Several In-N-Out locations have been announced for Middle Tennessee, with several already ...

The House began voting July 2, 2025, on whether to open debate for a sprawling Trump-backed domestic spending bill, but some GOP holdouts could endanger its passage. With such close margins, a tie ...

Therapeutic advances across the gynecologic cancer continuum have resulted in improvements in patient care and outcomes over the past decade, yet challenges remain. In ovarian cancer, the evolution of ...

Phase 2, multicenter study of frontline maintenance therapy with lifileucel plus pembrolizumab in advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...